SCHEMBL3046878

SCHEMBL3046878

COCOc1cc(C(=O)NC(C)(C)c2ccccc2)ccc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.56
ROCK1 Q13464 1/20 0.56
SMPD1 P17405 4/20 0.52
HDAC8 Q9BY41 2/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
TP53 P04637 1/20 0.47
ALDH1A1 P00352 4/20 0.47
GAA P10253 3/20 0.47
MAPT P10636 2/20 0.47
HPGD P15428 1/20 0.47
ALOX12 P18054 1/20 0.47
IMPDH2 P12268 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
KDM4E B2RXH2 2/20 0.45
LMNA P02545 2/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3049111 0.88 ROCK2 (0.51) ROCK2ROCK1SMPD1HDAC8HDAC1
SCHEMBL3039175 0.87 ROCK2 (0.47) ROCK2ROCK1HDAC8NPC1RAB9A
SCHEMBL3042553 0.85 ROCK2 (0.48) ROCK2ROCK1SMPD1HDAC8HDAC1
SCHEMBL3046859 0.84 ROCK2 (0.48) ROCK2ROCK1SMPD1HDAC8HDAC1
SCHEMBL3840595 0.81 KDM4E (0.49) ROCK2ROCK1NPC1RAB9AALDH1A1
SCHEMBL3048705 0.81 GPR132 (0.51) ROCK2ROCK1SMPD1NPC1RAB9A
SCHEMBL3039346 0.80 ROCK2 (0.57) ROCK2ROCK1NPC1RAB9ATP53
SCHEMBL3046092 0.76 CA12 (0.71) RAB9ALMNAHTT
SCHEMBL3042081 0.73 RAB9A (0.64) ROCK2ROCK1NPC1RAB9ATP53
SCHEMBL14083727 0.73 ROCK2 (0.60) ROCK2ROCK1HDAC8ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 ROCK2 2207/4885ROCK1 1831/4885SMPD1 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.